Dissecting genetics of spectrum of epilepsies with eyelid myoclonia by exome sequencing
Antonietta Coppola,S Krithika,Michele Iacomino,Dheeraj Bobbili,Simona Balestrini,Irene Bagnasco,Leonilda Bilo,Daniela Buti,Susanna Casellato,Claudia Cuccurullo,Edoardo Ferlazzo,Costin Leu,Lucio Giordano,Giuseppe Gobbi,Laura Hernandez-Hernandez,Nick Lench,Helena Martins,Stefano Meletti,Tullio Messana,Vincenzo Nigro,Michele Pinelli,Tommaso Pippucci,Ravishankara Bellampalli,Barbara Salis,Vito Sofia,Pasquale Striano,Salvatore Striano,Laura Tassi,Aglaia Vignoli,Anna Elisabetta Vaudano,Maurizio Viri,Ingrid E Scheffer,Patrick May,Federico Zara,Sanjay M Sisodiya
DOI: https://doi.org/10.1111/epi.17859
IF: 6.74
Epilepsia
Abstract:Objective: Epilepsy with eyelid myoclonia (EEM) spectrum is a generalized form of epilepsy characterized by eyelid myoclonia with or without absences, eye closure-induced seizures with electroencephalographic paroxysms, and photosensitivity. Based on the specific clinical features, age at onset, and familial occurrence, a genetic cause has been postulated. Pathogenic variants in CHD2, SYNGAP1, NEXMIF, RORB, and GABRA1 have been reported in individuals with photosensitivity and eyelid myoclonia, but whether other genes are also involved, or a single gene is uniquely linked with EEM, or its subtypes, is not yet known. We aimed to dissect the genetic etiology of EEM. Methods: We studied a cohort of 105 individuals by using whole exome sequencing. Individuals were divided into two groups: EEM- (isolated EEM) and EEM+ (EEM accompanied by intellectual disability [ID] or any other neurodevelopmental/psychiatric disorder). Results: We identified nine variants classified as pathogenic/likely pathogenic in the entire cohort (8.57%); among these, eight (five in CHD2, one in NEXMIF, one in SYNGAP1, and one in TRIM8) were found in the EEM+ subcohort (28.57%). Only one variant (IFIH1) was found in the EEM- subcohort (1.29%); however, because the phenotype of the proband did not fit with published data, additional evidence is needed before considering IFIH1 variants and EEM- an established association. Burden analysis did not identify any single burdened gene or gene set. Significance: Our results suggest that for EEM, as for many other epilepsies, the identification of a genetic cause is more likely with comorbid ID and/or other neurodevelopmental disorders. Pathogenic variants were mostly found in CHD2, and the association of CHD2 with EEM+ can now be considered a reasonable gene-disease association. We provide further evidence to strengthen the association of EEM+ with NEXMIF and SYNGAP1. Possible new associations between EEM+ and TRIM8, and EEM- and IFIH1, are also reported. Although we provide robust evidence for gene variants associated with EEM+, the core genetic etiology of EEM- remains to be elucidated.